Catalyst Wire Dossier Catalyst Wire Dossier

Poly-ICLC

poly-ICLC
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Poly-ICLC, covering 2008-05-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors [Phase 1]

See pricing